Annual EBIT
-$22.45 M
-$6.09 M-37.25%
31 December 2023
Summary:
ClearPoint Neuro annual earnings before interest & taxes is currently -$22.45 million, with the most recent change of -$6.09 million (-37.25%) on 31 December 2023. During the last 3 years, it has fallen by -$17.11 million (-320.49%). CLPT annual EBIT is now -583.72% below its all-time high of -$2.87 million.CLPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$5.17 M
-$433.00 K-9.14%
30 September 2024
Summary:
ClearPoint Neuro quarterly earnings before interest & taxes is currently -$5.17 million, with the most recent change of -$433.00 thousand (-9.14%) on 30 September 2024. Over the past year, it has dropped by -$275.00 thousand (-5.62%). CLPT quarterly EBIT is now -285.92% below its all-time high of $2.78 million, reached on 31 March 2014.CLPT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$18.85 M
-$275.00 K-1.48%
30 September 2024
Summary:
ClearPoint Neuro TTM earnings before interest & taxes is currently -$18.85 million, with the most recent change of -$275.00 thousand (-1.48%) on 30 September 2024. Over the past year, it has increased by +$3.38 million (+15.22%). CLPT TTM EBIT is now -1181.48% below its all-time high of -$1.47 million, reached on 30 June 2011.CLPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLPT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.3% | -5.6% | +15.2% |
| 3 y3 years | -320.5% | -38.2% | -74.0% |
| 5 y5 years | -333.1% | -468.5% | -354.4% |
CLPT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -320.5% | at low | -38.2% | +27.5% | -74.0% | +16.0% |
| 5 y | 5 years | -389.6% | at low | -468.5% | +27.5% | -354.4% | +16.0% |
| alltime | all time | -583.7% | at low | -285.9% | +27.5% | -1181.5% | +16.0% |
ClearPoint Neuro EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.17 M(+9.1%) | -$18.85 M(+1.5%) |
| June 2024 | - | -$4.74 M(+12.0%) | -$18.57 M(-11.4%) |
| Mar 2024 | - | -$4.23 M(-10.1%) | -$20.96 M(-6.6%) |
| Dec 2023 | -$22.45 M(+37.3%) | -$4.71 M(-3.9%) | -$22.45 M(+1.0%) |
| Sept 2023 | - | -$4.90 M(-31.3%) | -$22.23 M(+5.2%) |
| June 2023 | - | -$7.13 M(+24.8%) | -$21.13 M(+16.1%) |
| Mar 2023 | - | -$5.71 M(+27.2%) | -$18.20 M(+11.3%) |
| Dec 2022 | -$16.35 M(+21.7%) | -$4.49 M(+18.3%) | -$16.35 M(+3.2%) |
| Sept 2022 | - | -$3.79 M(-9.7%) | -$15.85 M(+0.3%) |
| June 2022 | - | -$4.20 M(+8.8%) | -$15.79 M(+4.6%) |
| Mar 2022 | - | -$3.86 M(-3.0%) | -$15.09 M(+12.3%) |
| Dec 2021 | -$13.44 M(+151.7%) | -$3.98 M(+6.5%) | -$13.44 M(+24.1%) |
| Sept 2021 | - | -$3.74 M(+6.8%) | -$10.83 M(+29.4%) |
| June 2021 | - | -$3.50 M(+58.8%) | -$8.37 M(+32.2%) |
| Mar 2021 | - | -$2.21 M(+60.1%) | -$6.33 M(+18.6%) |
| Dec 2020 | -$5.34 M(+16.4%) | -$1.38 M(+7.4%) | -$5.34 M(-0.7%) |
| Sept 2020 | - | -$1.28 M(-12.4%) | -$5.38 M(+7.5%) |
| June 2020 | - | -$1.46 M(+20.7%) | -$5.00 M(+3.6%) |
| Mar 2020 | - | -$1.21 M(-14.4%) | -$4.83 M(+5.4%) |
| Dec 2019 | -$4.58 M(-11.5%) | -$1.42 M(+55.8%) | -$4.58 M(+10.5%) |
| Sept 2019 | - | -$909.80 K(-29.5%) | -$4.15 M(-6.1%) |
| June 2019 | - | -$1.29 M(+33.6%) | -$4.42 M(-7.1%) |
| Mar 2019 | - | -$966.60 K(-1.4%) | -$4.76 M(-8.2%) |
| Dec 2018 | -$5.18 M(-17.7%) | -$979.90 K(-17.0%) | -$5.18 M(-14.3%) |
| Sept 2018 | - | -$1.18 M(-27.5%) | -$6.05 M(-0.5%) |
| June 2018 | - | -$1.63 M(+16.9%) | -$6.08 M(-2.6%) |
| Mar 2018 | - | -$1.39 M(-24.5%) | -$6.25 M(-0.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$6.29 M(-10.3%) | -$1.85 M(+52.0%) | -$6.29 M(+6.4%) |
| Sept 2017 | - | -$1.21 M(-32.2%) | -$5.91 M(-15.8%) |
| June 2017 | - | -$1.79 M(+24.2%) | -$7.02 M(+3.9%) |
| Mar 2017 | - | -$1.44 M(-1.6%) | -$6.76 M(-3.6%) |
| Dec 2016 | -$7.02 M(-2.3%) | -$1.47 M(-36.9%) | -$7.02 M(+9.2%) |
| Sept 2016 | - | -$2.32 M(+51.8%) | -$6.42 M(+59.4%) |
| June 2016 | - | -$1.53 M(-9.9%) | -$4.03 M(-23.2%) |
| Mar 2016 | - | -$1.70 M(+94.8%) | -$5.25 M(-27.0%) |
| Dec 2015 | -$7.19 M(+105.0%) | -$872.10 K(-1323.1%) | -$7.19 M(-9.4%) |
| Sept 2015 | - | $71.30 K(-102.6%) | -$7.93 M(-30.2%) |
| June 2015 | - | -$2.75 M(-24.4%) | -$11.36 M(+14.5%) |
| Mar 2015 | - | -$3.64 M(+124.5%) | -$9.93 M(+183.1%) |
| Dec 2014 | -$3.51 M(-46.8%) | -$1.62 M(-51.8%) | -$3.51 M(+1.2%) |
| Sept 2014 | - | -$3.36 M(+156.5%) | -$3.47 M(+9.2%) |
| June 2014 | - | -$1.31 M(-147.1%) | -$3.17 M(+2.8%) |
| Mar 2014 | - | $2.78 M(-276.2%) | -$3.09 M(-53.1%) |
| Dec 2013 | -$6.59 M(+100.6%) | -$1.58 M(-48.5%) | -$6.59 M(+66.2%) |
| Sept 2013 | - | -$3.07 M(+150.9%) | -$3.96 M(+11.0%) |
| June 2013 | - | -$1.22 M(+70.2%) | -$3.57 M(+25.2%) |
| Mar 2013 | - | -$718.10 K(-168.7%) | -$2.85 M(-13.1%) |
| Dec 2012 | -$3.28 M(-43.5%) | $1.05 M(-139.1%) | -$3.28 M(-40.7%) |
| Sept 2012 | - | -$2.68 M(+430.9%) | -$5.53 M(+29.1%) |
| June 2012 | - | -$504.00 K(-56.1%) | -$4.29 M(-18.4%) |
| Mar 2012 | - | -$1.15 M(-4.6%) | -$5.25 M(+28.0%) |
| Dec 2011 | -$5.81 M(-26.1%) | -$1.20 M(-15.8%) | -$4.10 M(+41.5%) |
| Sept 2011 | - | -$1.43 M(-2.8%) | -$2.90 M(+97.2%) |
| June 2011 | - | -$1.47 M | -$1.47 M |
| Dec 2010 | -$7.86 M | - | - |
FAQ
- What is ClearPoint Neuro annual earnings before interest & taxes?
- What is the all time high annual EBIT for ClearPoint Neuro?
- What is ClearPoint Neuro annual EBIT year-on-year change?
- What is ClearPoint Neuro quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly EBIT year-on-year change?
- What is ClearPoint Neuro TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ClearPoint Neuro?
- What is ClearPoint Neuro TTM EBIT year-on-year change?
What is ClearPoint Neuro annual earnings before interest & taxes?
The current annual EBIT of CLPT is -$22.45 M
What is the all time high annual EBIT for ClearPoint Neuro?
ClearPoint Neuro all-time high annual earnings before interest & taxes is -$2.87 M
What is ClearPoint Neuro annual EBIT year-on-year change?
Over the past year, CLPT annual earnings before interest & taxes has changed by -$6.09 M (-37.25%)
What is ClearPoint Neuro quarterly earnings before interest & taxes?
The current quarterly EBIT of CLPT is -$5.17 M
What is the all time high quarterly EBIT for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly earnings before interest & taxes is $2.78 M
What is ClearPoint Neuro quarterly EBIT year-on-year change?
Over the past year, CLPT quarterly earnings before interest & taxes has changed by -$275.00 K (-5.62%)
What is ClearPoint Neuro TTM earnings before interest & taxes?
The current TTM EBIT of CLPT is -$18.85 M
What is the all time high TTM EBIT for ClearPoint Neuro?
ClearPoint Neuro all-time high TTM earnings before interest & taxes is -$1.47 M
What is ClearPoint Neuro TTM EBIT year-on-year change?
Over the past year, CLPT TTM earnings before interest & taxes has changed by +$3.38 M (+15.22%)